Evaluating the ototoxicity of a antiMRSA peptide KR-12-a2

Conclusion In our experiment, topically applied KR-12-a2 solution did not cause hearing loss or cochlear damage in guinea pigs. The KR-12-a2 solution can be used as ototopical drops for treating MRSA otorrhea; however, further evaluations, such as the definition of optimal concentration and combination, are necessary.
Source: Brazilian Journal of Otorhinolaryngology - Category: ENT & OMF Source Type: research